PURPOSE: To investigate a potential influence of mydriatic eye drops on wavefront sensing with the Zywave aberrometer (Technolas Perfect Vision) in terms of predicted phoropter refraction (PPR) and higher order aberrations (HOA). METHODS: In this prospective study, 200 myopic eyes were measured in miosis and pharmacologically induced mydriasis with an aberrometer and automated refraction. One hundred eyes were dilated with tropicamide 0.5%+phenylephrine 2.5% eye drops (tropicamide/phenylephrine group), and the remaining 100 eyes with tropicamide 0.5% (tropicamide only group). The PPR values for a pupil diameter of 3.5 mm in miosis and mydriasis, respectively, were compared and correlated to the corresponding values of automated refraction. Changes in HOAs up to the 4th order were recorded. RESULTS: Predicted phoropter refraction values obtained in mydriasis were less myopic than in miosis. The spherical equivalent refraction of PPR differed by an average of 0.36 ± 0.36 diopters (D) in the tropicamide/phenylephrine group. In the tropicamide only group, the difference was 0.24 ± 0.43 D. Sphere of PPR differed by an average of 0.33 ± 0.36 D in the tropicamide/phenylephrine group and by an average of 0.24 ± 0.35 D in the tropicamide only group. Patient age had no major influence on the level of difference. Automated refraction yielded a smaller difference in spherical equivalent refraction. Changes in HOA root-mean-square were statistically significant. CONCLUSIONS: The cycloplegic effect of mydriatic eye drops should be taken into account when interpreting aberration measurements and planning a wavefront-guided ablation. Ideally, the use of mydriatic eye drops should be avoided to minimize refractive surprises. Copyright 2011, SLACK Incorporated.
PURPOSE: To investigate a potential influence of mydriatic eye drops on wavefront sensing with the Zywave aberrometer (Technolas Perfect Vision) in terms of predicted phoropter refraction (PPR) and higher order aberrations (HOA). METHODS: In this prospective study, 200 myopic eyes were measured in miosis and pharmacologically induced mydriasis with an aberrometer and automated refraction. One hundred eyes were dilated with tropicamide 0.5%+phenylephrine 2.5% eye drops (tropicamide/phenylephrine group), and the remaining 100 eyes with tropicamide 0.5% (tropicamide only group). The PPR values for a pupil diameter of 3.5 mm in miosis and mydriasis, respectively, were compared and correlated to the corresponding values of automated refraction. Changes in HOAs up to the 4th order were recorded. RESULTS: Predicted phoropter refraction values obtained in mydriasis were less myopic than in miosis. The spherical equivalent refraction of PPR differed by an average of 0.36 ± 0.36 diopters (D) in the tropicamide/phenylephrine group. In the tropicamide only group, the difference was 0.24 ± 0.43 D. Sphere of PPR differed by an average of 0.33 ± 0.36 D in the tropicamide/phenylephrine group and by an average of 0.24 ± 0.35 D in the tropicamide only group. Patient age had no major influence on the level of difference. Automated refraction yielded a smaller difference in spherical equivalent refraction. Changes in HOA root-mean-square were statistically significant. CONCLUSIONS: The cycloplegic effect of mydriatic eye drops should be taken into account when interpreting aberration measurements and planning a wavefront-guided ablation. Ideally, the use of mydriatic eye drops should be avoided to minimize refractive surprises. Copyright 2011, SLACK Incorporated.